Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 2 Interventional

Efficacy of SUN N4057 in Subjects With Acute Ischemic Stroke and Measurable Penumbra on Magnetic Resonance Imaging (MRI)

ClinicalTrials.gov ID: NCT00272909

Public ClinicalTrials.gov record NCT00272909. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 2, 2026, 10:18 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase IIb Randomized, Double-blind, Placebo-Controlled, Group-Sequential, Multicenter, Dose Finding Study of the Safety and Efficacy of SUN N4057 (Piclozotan) Administered for 72 Hours by Continuous Intravenous Infusion in Subjects With Acute Ischemic Stroke and Measurable Penumbra on MRI

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This research study is designed to evaluate the safety, tolerability, and efficacy of SUN N4057 (piclozotan) in subjects with acute ischemic stroke within 9 hours of the onset of symptoms.

Study identification

NCT ID
NCT00272909
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Lead sponsor
Daiichi Sankyo
Industry
Enrollment
43 participants

Conditions and interventions

Conditions

Eligibility (public fields only)

Age range
18 Years to 85 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 31, 2004
Primary completion
Sep 30, 2006
Completion
Dec 31, 2006
Last update posted
Oct 19, 2015

2004 – 2007

United States locations

U.S. sites
25
U.S. states
20
U.S. cities
25
Facility City State ZIP Site status
UCLA Stroke Network Los Angeles California 90024
San Francisco Clinical Research Center San Francisco California 94109
The Stroke Center at Hartford Hospital Hartford Connecticut 06102
Lakeland Regional Medical Center Lakeland Florida 33805
OCALA Neurodiagnostic Center Ocala Florida 34471
Southern Illinois University School of Medicine Springfield Illinois 62702
Ruan Neurology Clinic and Clinical Research Center Des Moines Iowa 50314
Via Christi Regional Medical Center Wichita Kansas 67214
University of Kentucky, Sanders Brown Center on Aging/Stroke Program Lexington Kentucky 40536
University of Massachusetts, Memorial Health Center, Department of Neurology Worcester Massachusetts 01655
Wayne State University Detroit Michigan 48201
Michigan State University, Sparrow Health System East Lansing Michigan 48824
St. Luke's Hospital Kansas City Missouri 64111
Advance Neurology Specialists Great Falls Montana 59405
St. Francis Medical Center Trenton New Jersey 08629
SUNY at Stony Brook, University Hospital at Stony Brook Stony Brook New York 11794
Moses Cone Hospital Greensboro North Carolina 27401
Clinical Research Center of Winston-Salem Winston-Salem North Carolina 27103
Summa Health System Neurology and Neuroscience Associates Akron Ohio 44309
Chattanooga Neurology Associates Chattanooga Tennessee 37404
Methodist University Hospital Memphis Tennessee 38104
The Methodist Hospital Neurological Institute Houston Texas 77030
INOVA Research Center Falls Church Virginia 22042
Charleston Area Medical Center Health Education and Research Institute Charleston West Virginia 25304
Medical College of Wisconsin Milwaukee Wisconsin 53226

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 22 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00272909, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 19, 2015 · Synced Sep 2, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00272909 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →